1. Home
  2. VCEL vs GNL Comparison

VCEL vs GNL Comparison

Compare VCEL & GNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • GNL
  • Stock Information
  • Founded
  • VCEL 1989
  • GNL 2011
  • Country
  • VCEL United States
  • GNL United States
  • Employees
  • VCEL N/A
  • GNL N/A
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • GNL Real Estate Investment Trusts
  • Sector
  • VCEL Health Care
  • GNL Real Estate
  • Exchange
  • VCEL Nasdaq
  • GNL Nasdaq
  • Market Cap
  • VCEL 2.1B
  • GNL 1.7B
  • IPO Year
  • VCEL 1997
  • GNL N/A
  • Fundamental
  • Price
  • VCEL $41.83
  • GNL $7.64
  • Analyst Decision
  • VCEL Strong Buy
  • GNL Buy
  • Analyst Count
  • VCEL 8
  • GNL 4
  • Target Price
  • VCEL $62.00
  • GNL $9.50
  • AVG Volume (30 Days)
  • VCEL 430.3K
  • GNL 2.1M
  • Earning Date
  • VCEL 07-31-2025
  • GNL 08-05-2025
  • Dividend Yield
  • VCEL N/A
  • GNL 9.95%
  • EPS Growth
  • VCEL 521.85
  • GNL N/A
  • EPS
  • VCEL 0.05
  • GNL N/A
  • Revenue
  • VCEL $238,541,000.00
  • GNL $789,545,000.00
  • Revenue This Year
  • VCEL $23.03
  • GNL N/A
  • Revenue Next Year
  • VCEL $24.52
  • GNL N/A
  • P/E Ratio
  • VCEL $805.02
  • GNL N/A
  • Revenue Growth
  • VCEL 14.80
  • GNL 38.85
  • 52 Week Low
  • VCEL $37.39
  • GNL $6.51
  • 52 Week High
  • VCEL $63.00
  • GNL $9.11
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 47.28
  • GNL 51.00
  • Support Level
  • VCEL $40.53
  • GNL $7.32
  • Resistance Level
  • VCEL $43.57
  • GNL $7.66
  • Average True Range (ATR)
  • VCEL 1.67
  • GNL 0.16
  • MACD
  • VCEL -0.10
  • GNL 0.01
  • Stochastic Oscillator
  • VCEL 27.68
  • GNL 58.91

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About GNL Global Net Lease Inc.

Global Net Lease Inc is a real estate investment trust that manages a globally diversified portfolio of commercial real estate properties. The company is engaged in the ownership, management, operating, lease, acquisition, investment, and sale of the portfolio assets. Its segments include Industrial & Distribution; Multi-Tenant Retail; Single-Tenant Retail; and office. The company derives maximum revenue from industrial and distribution segment. The company geographically operates in Unites States, United Kingdom, Canada and Europe.

Share on Social Networks: